Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Dec;63(12):1368-1372.
doi: 10.1111/myc.13185. Epub 2020 Oct 1.

Putative invasive pulmonary aspergillosis in critically ill patients with COVID-19: An observational study from New York City

Hayato Mitaka  1 , David C Perlman  1 , Waleed Javaid  1 , Nadim Salomon  1
Affiliations
Case Reports

Putative invasive pulmonary aspergillosis in critically ill patients with COVID-19: An observational study from New York City

Hayato Mitaka et al. Mycoses. 2020 Dec.

Abstract

Background: Critically ill patients with coronavirus disease-2019 (COVID-19) are at the theoretical risk of invasive pulmonary aspergillosis (IPA) due to known risk factors.

Patients/methods: We aimed to describe the clinical features of COVID-19-associated pulmonary aspergillosis at a single centre in New York City. We performed a retrospective chart review of all patients with COVID-19 with Aspergillus isolated from respiratory cultures.

Results: A total of seven patients with COVID-19 who had one or more positive respiratory cultures for Aspergillus fumigatus were identified, all of whom were mechanically ventilated in the ICU. Four patients were classified as putative IPA. The median age was 79 years, and all patients were male. The patients had been mechanically ventilated for a mean of 6.8 days (range: 1-14 days) before Aspergillus isolation. Serum galactomannan level was positive for only one patient. The majority of our cases received much higher doses of glucocorticoids than the dosage with a proven mortality benefit. All four patients died.

Conclusions: Vigilance for secondary fungal infections will be needed to reduce adverse outcomes in critically ill patients with COVID-19.

Keywords: COVID-19; SARS-CoV-2; acute respiratory distress syndrome; pulmonary aspergillosis.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest to declare.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wauters J, Baar I, Meersseman P, et al. Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Med. 2012;38(11):1761‐1768. - PMC - PubMed
    1. Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6(10):782‐792. - PubMed
    1. Blaize M, Mayaux J, Nabet C, et al. Fatal invasive aspergillosis and coronavirus disease in an immunocompetent patient. Emerg Infect Dis. 2020;26(7):1636‐1637. - PMC - PubMed
    1. van Arkel ALE, Rijpstra TA, Belderbos HNA, van Wijngaarden P, Verweij PE, Bentvelsen RG. COVID‐19‐associated pulmonary aspergillosis. Am J Respir Crit Care Med. 2020;202(1):132‐135. - PMC - PubMed
    1. Koehler P, Cornely OA, Böttiger BW, et al. COVID‐19 associated pulmonary aspergillosis. Mycoses. 2020;63(6):528‐534. - PMC - PubMed

MeSH terms